RECENT NEWS

Roche has announced the launch of the Institute of Human Biology (IHB) focusing on advancing research in the field of human model systems such as organoids. Leveraging human model systems, the institute aims to accelerate drug discovery and development by improving the understanding of how organs function and how diseases develop, ultimately bringing medicines to patients faster.

Gyros Protein Technologies, a provider of peptide synthesisers and reagents and a pioneer in automated nanolitre-scale immunoassays, has announced the introduction of Gyrolab Generic Cyno Anti-Drug Antibodies (ADA) Kit Reagents, for the detection of circulating immune complexes of human IgG with cyno anti-human IgG.

Hospitals are now being asked to work towards a 10-day turnaround when delivering diagnostic test results to patients who have received an urgent referral for suspected cancer, as part of new plans to see and treat people for cancer as early as possible.

A statutory instrument has been laid in the UK Parliament, which will enable an extended timeframe for acceptance of CE-marked medical devices on the Great Britain market, the MHRA has announced.

US-based health services company Curative has announced the spin-off of Sensible Diagnostics, with the aim of commercialising its ground-breaking point-of-care PCR testing platform.

Pathology diagnostics service provider Diagnexia UK - owned by Deciphex – recently celebrated the launch of its expanded facility at Exeter Science Park.

HORIBA UK Veterinary is supporting Strangles Awareness Week 2023 to educate and improve biosecurity for this devastating equine specific disease.

Tecan and DYNEX Technologies have announced a partnership to broaden the availability of ELISA products in the US. Customers will now have direct access to Tecan’s ELISA-related kits and comprehensive portfolio of reagents alongside DYNEX's fully automated ELISA workstations.

Evident’s new Slideview VS200 v. 4.1 software supports a host of new features, including the SILA optical sectioning device that enables users to obtain high-contrast images from deep within a sample.

The Council of Europe Steering Committee for Human Rights in the fields of Biomedicine and Health (CDBIO) has published a report regarding the public dialogue on genomic medicine – marking the date of the 70th anniversary of the discovery of the DNA double helix.

The IBMS has been entrusted with running Harvey’s Gang laboratory tours to ensure many more young patients and members can benefit from the initiative. As the founder and IBMS member Malcolm Robinson and the Harvey’s Gang trustees have decided to wind down the charity, the IBMS is stepping in to become the new custodian.

Digital pathology and image management firm Indica Labs, and Lunit, a leading medical AI software platform company focused on cancer biomarkers have announced an agreement to provide a fully interoperable solution between Indica Labs’ HALO AP image management software platform and Lunit’s suite of AI pathology products.

Digital and computational pathology firm Proscia has announced that Virscio, a leading provider of translational research and development services, has deployed Concentriq for Research. The contract research organisation (CRO) is leveraging Proscia’s flagship software platform to provide faster, more informed drug safety insights, helping its sponsors to improve research and development efficiency.

A study led by the University of St Andrews suggests that a frequently used medical test for heart injury could one day be used to help COVID-19 patients avoid hospitalisation.

Marking Infertility Awareness Week (23-29 April), a French laboratory has recently been helped by Beckman Coulter Diagnostics to automate a crucial step in the IVF process.

A new clinical study into managing high-risk bleeding has demonstrated the effectiveness of the Quantra Haemostasis Analyser, Stago UK’s novel point-of-care solution. This is the first time that Quantra has featured in an interventional study.

Lab Innovations will return to the NEC, Birmingham, on 1-2 November 2023, to champion sustainability and innovation in the laboratory industry. This year’s exhibition is already shaping up to be a must-attend event, with over 84% of the exhibition space already sold, despite increasing the floorplan at this year’s show to accommodate more exhibitors than ever.

Leica Biosystems has announced the European launch of BOND-PRIME, a faster, more advanced staining solution. BOND-PRIME delivers all elements of Universal Access – able to handle any slide, in any combination, at any time, using any reagent.

Philips and Saint-Joseph Hospital & Marie-Lannelongue Hospital, one of France’s leading centres of excellence in cancer care, have announced the first steps in a partnership to fully integrate digital pathology into the Saint-Joseph and Marie Lannelongue hospitals’ enterprise imaging solutions.

Time is running out to secure best-price tickets for IBMS Congress, with the Premium Early Discount rates coming to an end on 30 April.